Literature DB >> 8273124

Cytokine generation in stored platelet concentrates.

G Stack1, E L Snyder.   

Abstract

BACKGROUND: Cytokines, because of the nature of their immunoinflammatory actions, are potential mediators of the symptom complex of nonhemolytic transfusion reactions. One possible source of cytokines in the transfusion setting is the stored blood component itself. STUDY DESIGN AND METHODS: To test this possibility, the plasma portion of stored platelet concentrates (PCs) was assayed for the presence of interleukins 1 beta (IL-1 beta), 6 (IL-6), and 8 (IL-8) and tumor necrosis factor alpha (TNF-alpha). Samples were taken from PCs obtained from the inventory of a regional blood center (n = 120; 30 each of 2-, 3-, 4-, and 5-day-old units).
RESULTS: Detectable levels of IL-8 were measured in 59 percent of the PCs sampled, ranging from 30 percent of the 2-day-old units to 83 percent of the 5-day-old units. The median IL-8 concentration ranged from undetectable levels in 2-day-old units up to 1100 pg per mL in 5-day-old units. The mean IL-8 concentration in 5-day-old units, 11,600 pg per mL, was 100 times the mean for 2-day-old units, which was 116 pg per mL (p < 0.0001). The highest levels of IL-8, 50,000 to 200,000 pg per mL, in general were found in units with the longest storage times and highest white cell counts. Sequential sampling of 17 individual PCs over 7 days of storage confirmed that IL-8 increases progressively with increasing storage time. Parallel, but smaller, increases in IL-1 beta were observed in those units with high IL-8 concentrations. TNF-alpha was detected in 3 (10%) of 30 five-day-old PCs, but never exceeded 55 pg per mL in any unit tested. IL-6 at levels of 740 and 508 pg per mL was detected in two 5-day-old units with high white cell counts of 9500 and 14,800 per microL, respectively, but not in 21 additional units tested with white cells < or = 9200 per microL or storage time of < or = 2 days. White cell reduction by third-generation filters on Day 1 of platelet storage prevented the generation of IL-8 and IL-1 beta to Day 5 of storage.
CONCLUSION: Although IL-8 achieved levels in some units of PCs that appear capable of causing physiologic changes, the potential adverse effect on transfusion recipients of the infusion of cytokines in PCs remains to be investigated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8273124     DOI: 10.1046/j.1537-2995.1994.34194098597.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  27 in total

1.  New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells.

Authors:  Katie Grimshaw; Julie Sahler; Sherry L Spinelli; Richard P Phipps; Neil Blumberg
Journal:  Transfusion       Date:  2011-04       Impact factor: 3.157

2.  Partial splenic embolization in myelodysplastic syndrome associated with immune thrombocytopenia.

Authors:  Hakan Ozdogu; Can Boga; Levent Oğuzkurt; Ebru Kizilkilic
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

Review 3.  Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice?

Authors:  Terrence L Geiger; Scott C Howard
Journal:  Transfus Med Rev       Date:  2007-01

4.  Presence of high levels of leukocyte-associated interleukin-8 upon cell activation and in patients with sepsis syndrome.

Authors:  C Marie; C Fitting; C Cheval; M R Losser; J Carlet; D Payen; K Foster; J M Cavaillon
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Evaluation of a red cell leukofilter performance and effect of buffy coat removal on filtration efficiency and post filtration storage.

Authors:  Atul Sonker; Anju Dubey; Rajendra Chaudhary
Journal:  Indian J Hematol Blood Transfus       Date:  2013-04-26       Impact factor: 0.900

6.  There is no change in soluble leucocyte selectin concentrations in whole blood after 48 hours of storage at 4 °C.

Authors:  Melville Bradley
Journal:  Blood Transfus       Date:  2014-09-12       Impact factor: 3.443

Review 7.  Platelet-rich plasma in the foot and ankle.

Authors:  Peter R Henning; Benjamin J Grear
Journal:  Curr Rev Musculoskelet Med       Date:  2018-12

8.  Mirasol Pathogen Reduction Technology treatment does not affect acute lung injury in a two-event in vivo model caused by stored blood components.

Authors:  C C Silliman; S Y Khan; J Bradley Ball; M R Kelher; S Marschner
Journal:  Vox Sang       Date:  2009-11-25       Impact factor: 2.144

9.  Platelet tissue factor synthesis in type 2 diabetic patients is resistant to inhibition by insulin.

Authors:  Anja J Gerrits; Cornelis A Koekman; Timon W van Haeften; Jan Willem N Akkerman
Journal:  Diabetes       Date:  2010-03-03       Impact factor: 9.461

10.  Prerequisites for cytokine measurements in clinical trials with multiplex immunoassays.

Authors:  Wilco de Jager; Katarzyna Bourcier; Ger T Rijkers; Berent J Prakken; Vicki Seyfert-Margolis
Journal:  BMC Immunol       Date:  2009-09-28       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.